Triad Wealth Partners LLC Grows Position in Agilent Technologies, Inc. $A

Triad Wealth Partners LLC raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 32.4% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,851 shares of the medical research company’s stock after purchasing an additional 698 shares during the period. Triad Wealth Partners LLC’s holdings in Agilent Technologies were worth $336,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the 1st quarter worth $30,000. Opal Wealth Advisors LLC purchased a new stake in Agilent Technologies during the first quarter valued at about $31,000. Ransom Advisory Ltd acquired a new stake in Agilent Technologies during the first quarter worth about $32,000. Central Pacific Bank Trust Division purchased a new position in shares of Agilent Technologies in the 2nd quarter worth about $33,000. Finally, Zions Bancorporation National Association UT acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $38,000.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Barclays raised their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a report on Thursday. Robert W. Baird raised their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a report on Saturday, September 27th. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday. Finally, Evercore ISI cut their price objective on Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating on the stock in a research report on Thursday, August 28th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, Agilent Technologies currently has a consensus rating of “Hold” and a consensus price target of $142.17.

Agilent Technologies Trading Up 2.3%

Shares of NYSE A opened at $141.91 on Friday. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The stock’s 50 day moving average price is $122.80 and its two-hundred day moving average price is $116.41. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84. The stock has a market capitalization of $40.23 billion, a P/E ratio of 33.31, a PEG ratio of 4.53 and a beta of 1.26.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.37. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business’s quarterly revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be issued a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.